Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis.

Literature DB >> 2550234

Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis.

Abstract

MICs and MBCs of four new macrolides (azithromycin, clarithromycin, dirithromycin and roxithromycin) and two older macrolides (erythromycin and josamycin) for Bordetella pertussis and Bordetella parapertussis were determined. The activity of the new macrolides was as good as that of erythromycin, while josamycin was slightly less active. Bordetella parapertussis was more resistant than Bordetella pertussis.

Entities: Chemical Disease

Mesh：

Substances：

Year: 1989 PMID： 2550234 DOI： 10.1007/BF01968151

Source DB: PubMed Journal: Eur J Clin Microbiol Infect Dis ISSN： 0934-9723 Impact factor: 3.267

4 in total

1. Antimicrobial susceptibilities of Bordetella species isolated in a Multicenter Pertussis Surveillance Project.

Authors: T A Kurzynski; D M Boehm; J A Rott-Petri; R F Schell; P E Allison
Journal: Antimicrob Agents Chemother Date: 1988-01 Impact factor: 5.191

Review 2. Antimicrobial susceptibility of Bordetella pertussis (Part I).

Authors: J E Hoppe; A Haug
Journal: Infection Date: 1988 Mar-Apr Impact factor: 3.553

3. Susceptibility of Bordetella pertussis and Bordetella parapertussis to 24 antibiotics.

Authors: J E Hoppe; A Haug; K Botzenhart
Journal: Chemotherapy Date: 1987 Impact factor: 2.544

4. Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides.

Authors: D J Hardy; D M Hensey; J M Beyer; C Vojtko; E J McDonald; P B Fernandes
Journal: Antimicrob Agents Chemother Date: 1988-11 Impact factor: 5.191

4 in total

18 in total

1. In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to seven fluoroquinolones.

Authors: J E Hoppe; C G Simon
Journal: Antimicrob Agents Chemother Date: 1990-11 Impact factor: 5.191

Review 2. State of art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis.

Authors: J E Hoppe
Journal: Infection Date: 1998 Jul-Aug Impact factor: 3.553

3. In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine).

Authors: J E Hoppe; A Bryskier
Journal: Antimicrob Agents Chemother Date: 1998-04 Impact factor: 5.191

4. Update of epidemiology, diagnosis, and treatment of pertussis.

Authors: J E Hoppe
Journal: Eur J Clin Microbiol Infect Dis Date: 1996-03 Impact factor: 3.267

Review 5. Macrolide antibiotics.

Authors: R C Gordon
Journal: Indian J Pediatr Date: 1998 Jan-Feb Impact factor: 1.967

Review 6. Rational prescribing of antibacterials in ambulatory children.

Authors: J E Hoppe
Journal: Pharmacoeconomics Date: 1996-12 Impact factor: 4.981

Review 7. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors: Seema Mattoo; James D Cherry
Journal: Clin Microbiol Rev Date: 2005-04 Impact factor: 26.132

8. In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to four fluoroquinolones (levofloxacin, d-ofloxacin, ofloxacin, and ciprofloxacin), cefpirome, and meropenem.

Authors: J E Hoppe; E Rahimi-Galougahi; G Seibert
Journal: Antimicrob Agents Chemother Date: 1996-03 Impact factor: 5.191

Review 9. Clarithromycin clinical pharmacokinetics.

Authors: F Fraschini; F Scaglione; G Demartini
Journal: Clin Pharmacokinet Date: 1993-09 Impact factor: 6.447

Review 10. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.

Authors: D H Peters; H A Friedel; D McTavish
Journal: Drugs Date: 1992-11 Impact factor: 9.546